Scarica l'app Stockscreener
85.11
0.82%
-0.70
Dopo l'orario di chiusura:
85.02
-0.09
-0.11%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Medtronic Plc Borsa (MDT) Ultime notizie
Product liability lawsuits target Medtronic, Boston Scientific spinal cord stim tech - MassDevice
Electroceuticals Market Top PlayersMedtronic Plc (Ireland), - openPR.com
Weak Financial Prospects Seem To Be Dragging Down Medtronic plc (NYSE:MDT) Stock - simplywall.st
Healthcare Digital Twins Market Size to Hit USD 6.80 Billion by 2032, growing at 25.7% CAGR, says Coherent Market Insights - GlobeNewswire Inc.
Medtronic plc (MDT): Among the Best High-Yield Dividend Stocks for 2025 and Beyond - Insider Monkey
Is Medtronic plc (MDT) the Best Medical Device Stock to Buy Now? - Insider Monkey
Medtronic (MDT) Rises Yet Lags Behind Market: Some Facts Worth Knowing - Yahoo Finance
Is Medtronic Stock a Buy Pre-Q4 Earnings? Key Metrics to Watch - The Globe and Mail
Medtronic to announce financial results for its fourth quarter and full fiscal year 2025 - The Globe and Mail
11 Best Medical Device Stocks to Buy Now - Insider Monkey
What Are Wall Street Analysts’ Target Price for Medtronic Stock? - Nasdaq
New survey: 1 in 3 women have not talked to their doctor about heart health, the #1 killer of women - Medtronic
Urology Surgical Instruments Market Top PlayersMedtronic, - openPR.com
What Are Wall Street Analysts’ Target Price For Medtronic Stock? - Barchart.com
Intubation Tubes Market Detailed in New Research Report By 2032 | - openPR.com
Medtronic (MDT) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
A Look At The Fair Value Of Medtronic plc (NYSE:MDT) - Yahoo Finance
Medtronic (MDT) Rises Higher Than Market: Key Facts - Yahoo Finance
Medtronic wins FDA approval for defibrillation lead - MedTech Dive
Medtronic Education Program Opens Doors for Employees - Yahoo Finance
Medtronic study backs automated neuromod for overactive bladder - MassDevice
Medtronic and Abbott's game-changing partnership for CGM integration - Today's Medical Developments
4 PFA studies in the spotlight at Heart Rhythm 2025 - MedTech Dive
Earnings Preview: What To Expect From Medtronic’s Report - Nasdaq
Medtronic Gets FDA Nod for Smallest-Diameter, Lumenless Defibrillation Lead - Diagnostic and Interventional Cardiology
Medtronic has positive VenaSeal data - MassDevice
Functional Endoscopic Sinus Surgery Market Key Players - openPR.com
Medtronic submits Hugo soft tissue robot for FDA approval - MedTech Dive
Medtronic inks new distro agreement for Retia Medical Argos cardiac output monitor - MassDevice
The Zacks Analyst Blog Highlights Abbott Laboratories, Boston Scientific and Medtronic - Zacks Investment Research
Medtronic Trial for Robotic-Assisted Surgery System Meets Safety, Effectiveness Primary Endpoints - marketscreener.com
Medtronic’s defibrillation lead gains FDA approval for use in right ventricle - Yahoo Finance
Medtronic Files for FDA Submission for the Hugo Robotic System - Medical Device and Diagnostic industry
Medtronic Affera™ pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients - BioSpace
Smoke Evacuation System Market to Garner $196.4 Million by 2027 | - openPR.com
Medtronic receives US FDA approval for smallest-diameter, lumenless defibrillation lead, the OmniaSecure lead - Pharmabiz.com
Medtronic (MDT) Showcases Positive AFib Treatment Results at Key Medical Conference | MDT Stock News - GuruFocus
Medtronic (MDT) Reveals Promising AFib Treatment Outcomes with S - GuruFocus
Medtronic reports more positive outcomes with Affera PFA tech - MassDevice
Medtronic Affera pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients - Investing News Network
Medtronic PLC Says Sphere-360 Study Shows 88% Freedom From Arrhythmia Recurrence - marketscreener.com
Medtronic submits Hugo surgical robot to FDA, meets trial endpoints - MassDevice
Medtronic (MDT) Seeks FDA Approval for Hugo Robotic Surgery Syst - GuruFocus
0.14%
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):